Northern Trust’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $209M | Buy |
2,985,329
+33,288
| +1% | +$1.72M | 0.02% | 499 |
|
|
2026
Q1 | $150M | Sell |
2,952,041
-50,537
| -2% | -$2.36M | 0.02% | 585 |
|
|
2025
Q4 | $88.5M | Buy |
3,002,578
+97,069
| +3% | +$2.64M | 0.01% | 790 |
|
|
2025
Q3 | $75M | Sell |
2,905,509
-184,772
| -6% | -$5.15M | 0.01% | 878 |
|
|
2025
Q2 | $85.3M | Sell |
3,090,281
-29,345
| -0.9% | -$773K | 0.01% | 789 |
|
|
2025
Q1 | $88.4M | Buy |
3,119,626
+160,572
| +5% | +$5.7M | 0.01% | 759 |
|
|
2024
Q4 | $123M | Buy |
2,959,054
+354,871
| +14% | +$17M | 0.02% | 627 |
|
|
2024
Q3 | $174M | Sell |
2,604,183
-235,084
| -8% | -$21.6M | 0.03% | 472 |
|
|
2024
Q2 | $337M | Sell |
2,839,267
-29,687
| -1% | -$3.76M | 0.06% | 291 |
|
|
2024
Q1 | $306M | Sell |
2,868,954
-103,042
| -3% | -$10.4M | 0.05% | 321 |
|
|
2023
Q4 | $296M | Buy |
2,971,996
+940
| +0% | +$79.1K | 0.05% | 328 |
|
|
2023
Q3 | $307M | Buy |
2,971,056
+55,177
| +2% | +$6.15M | 0.06% | 305 |
|
|
2023
Q2 | $354M | Sell |
2,915,879
-287,565
| -9% | -$38.4M | 0.07% | 280 |
|
|
2023
Q1 | $492M | Sell |
3,203,444
-67,114
| -2% | -$11.1M | 0.1% | 202 |
|
|
2022
Q4 | $587M | Buy |
3,270,558
+44,752
| +1% | +$7.32M | 0.12% | 169 |
|
|
2022
Q3 | $381M | Sell |
3,225,806
-121,782
| -4% | -$18.5M | 0.09% | 223 |
|
|
2022
Q2 | $478M | Sell |
3,347,588
-155,737
| -4% | -$22.3M | 0.1% | 189 |
|
|
2022
Q1 | $603M | Buy |
3,503,325
+20,416
| +0.6% | +$3.44M | 0.11% | 172 |
|
|
2021
Q4 | $885M | Buy |
3,482,909
+23,555
| +0.7% | +$6.89M | 0.14% | 128 |
|
|
2021
Q3 | $1.33B | Buy |
3,459,354
+1,510,266
| +77% | +$557M | 0.24% | 81 |
|
|
2021
Q2 | $458M | Buy |
1,949,088
+112,251
| +6% | +$20.1M | 0.08% | 224 |
|
|
2021
Q1 | $241M | Buy |
1,836,837
+11,466
| +0.6% | +$1.66M | 0.04% | 370 |
|
|
2020
Q4 | $191M | Buy |
1,825,371
+1,600
| +0.1% | +$162K | 0.04% | 425 |
|
|
2020
Q3 | $129M | Sell |
1,823,771
-5,590
| -0.3% | -$390K | 0.03% | 477 |
|
|
2020
Q2 | $117M | Buy |
1,829,361
+729,335
| +66% | +$39.9M | 0.03% | 490 |
|
|
2020
Q1 | $32.9M | Buy |
1,100,026
+129,361
| +13% | +$2.98M | 0.01% | 1052 |
|
|
2019
Q4 | $19M | Buy |
970,665
+39,242
| +4% | +$696K | ﹤0.01% | 1764 |
|
|
2019
Q3 | $14.8M | Buy |
931,423
+743,929
| +397% | +$11M | ﹤0.01% | 1891 |
|
|
2019
Q2 | $2.74M | Buy |
187,494
+138,031
| +279% | +$2.96M | ﹤0.01% | 2881 |
|
|
2019
Q1 | $1.01M | Buy |
+49,463
| New | +$918K | ﹤0.01% | 3355 |
|
Other funds holding MRNA
TP
Northern Trust's MRNA Position: Q2 2026 in Review
Northern Trust increased its Moderna (MRNA) stake by 1.1% in Q2 2026, buying an estimated $1.72M and bringing the position to 2,985,329 shares worth $209M. The position accounts for 0.02% of the portfolio, ranked #499.
Northern Trust first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.33B in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Northern Trust held 2,985,329 shares of Moderna worth $209M as of Q2 2026.
- Northern Trust bought 33,288 Moderna shares in Q2 2026, an estimated $1.72M.
- Moderna made up 0.02% of Northern Trust's portfolio in Q2 2026, its #499 holding.
- Northern Trust first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
- Northern Trust's Moderna position peaked at $1.33B in Q3 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.